Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DNTH compared with COGT: revenue, margins and what each company keeps, and the suppliers and customers both name
DNTH
Dianthus Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
COGT
Cogent Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DNTH
Dianthus Therapeutics, Inc.
vs
COGT
Cogent Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
DNTH
Dianthus Therapeutics, Inc.
Change
82.53
· pre 82.70
· delayed
Mkt cap
$4.6B
Revenue
$761,000
Q2 FY26
Revenue
$6M
FY24
COGT
Cogent Biosciences, Inc.
Change
31.05
· pre 32.10
· delayed
Pre-market
Nov 4 '26
delayed
Mkt cap
$5.4B
Revenue
—
Revenue
—
vs
Compare
Pre-market
Nov 4 '26
delayed
DNTH
Dianthus Therapeutics, Inc.
vs
COGT
Cogent Biosciences, Inc.
82.53
pre 82.70
delayed
Price
31.05
pre 32.10
delayed
$4.6B
Mkt cap
$5.4B
Q2 FY26
$761,000
Revenue
—
FY24
$6M
Revenue
—
Change
Change
DNTH
82.53
vs
COGT
31.05
Pre-market
Nov 4 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
DNTH: latest quarter is a loss; flow not drawable. COGT: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only DNTH
3
—
Nanjing Leads Biolabs
unlisted
supplier
—
IONTAS
unlisted
supplier
—
Tenacia Biotechnology (Hong Kong)
unlisted
customer
Shared
0
No disclosed counterparties: COGT.
Only COGT
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DNTH, solid
COGT, dashed